Chat with us, powered by LiveChat

Read-across masterclass: How to facilitate your acceptable intake limit setting for nitrosamines

Read-across is a popular data gap filling technique which has recently gained recognition in regulatory guidance as a valuable tool for identifying suitable surrogates in establishing Acceptable Intake (AI) limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs).

Join us for an informative webinar where we unveil Acrostic, our novel read-across solution designed to facilitate decision-making when determining AI limits for nitrosamine compounds. Learn how Acrostic utilises a standardised, reliable and transparent framework through worked NDSRI examples.

Our esteemed presenters include:

  • Dr David Ponting, Principal Scientist at Lhasa Limited

David will delve into the background of the Carcinogenic Potency Categorisation Approach (CPCA) for N-nitrosamine impurity assignment and demonstrate how Acrostic complements the CPCA in calculating appropriate AI limits.

  • Dr Charlie Modlin, Senior Application Scientist at Lhasa Limited

Charlie will introduce Acrostic, our innovative in silico read-across tool, and showcase its purposeful workflow through examples, offering insights into how Acrostic evaluates nitrosamine carcinogenicity.

The webinar will conclude with a live Q&A session, providing an opportunity to engage directly with our experts and gain a deeper understanding of using read-across for nitrosamine risk assessment.

Register below to join our read-across masterclass and elevate your understanding of AI limit setting for nitrosamines!







Where it is lawful to do so, we will opt you into our marketing emails. See our privacy policy for more information.